MedPath

A prevention system for the blood donation related neuropathic pain (BDRNP)- prospective multi-center study

Not Applicable
Conditions
neuropathic pain
Registration Number
JPRN-UMIN000033096
Lead Sponsor
Japanease Redd Cross
Brief Summary

In conclusion, we found that the total number, including severe cases, of BDRNP; and total number of BDRNP cases without cutaneous nerve injury, were significantly reduced when compared with those in the previous 5 years. Based on previous pilot studies and these results, the SFCPD hypothesis was accepted as mechanism of BDRNP. To the best of our knowledge, our cost-free and convenient preliminary intervention including SAEFP test based on the SFCPD hypothesis, is the first study to report improvements in the occurrence of BDRNP.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
15000
Inclusion Criteria

Not provided

Exclusion Criteria

donator who refused SAEFP test

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the occurrence of BDRNP
Secondary Outcome Measures
NameTimeMethod
Pain duration or severity of BDRNP
© Copyright 2025. All Rights Reserved by MedPath